Evidence map›Paper›PMID 29574722›Full record

ReviewJournal of cellular physiology2018

TUSC7: A novel tumor suppressor long non-coding RNA in human cancers.

Na Li, Ke Shi, Wei Li

Abstract readReview
In one paragraph

Review in Journal of cellular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Rewriting the RNA code: an mFrontiers in immunology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Na LiDepartment of Pathology, the First Affiliated Hospital of Hunan University of Medicine, Huaihua, Hunan Province, P.R. China.
Ke ShiDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan Province, P.R. China.
Wei LiDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan Province, P.R. China.ORCID http://orcid.org/0000-0002-8581-2897

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidences has shown that tumor suppressor candidate 7 (TUSC7) as a putatively tumor suppressor gene in various tumors. The low-expression of TUSC7 is related to poor prognosis, and increased the proliferation rate of tumor cells. Over-expression of TUSC7 could suppress tumor cell proliferation, migration, invasion, and colony formation, suggesting that TUSC7 might be a diagnostic and prognostic biomarker, as well as therapeutic target. In this review, we summarized the molecular mechanism and clinical significance of TUSC7 in tumorigenesis, tumor progression, and prognosis.

Indexed as

AnimalsBiomarkers, TumorCarcinogenesisGenes, Tumor SuppressorHumansNeoplasmsPrognosisRNA, Long NoncodingBiomarkers, Tumorloc285194 LncRNA, humanRNA, Long Noncodingprognosistumorigenesistumor suppressorTUSC7

Identifiers

PMID29574722
PMCPMC13482436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.